Christian Glennie
Stock Analyst at Stifel Nicolaus
(2.72)
# 2,828
Out of 4,486 analysts
102
Total ratings
36.5%
Success rate
2.9%
Average return
Main Sectors:
Stocks Rated by Christian Glennie
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AIM: AMS Advanced Medical Solutions Group plc | Maintained: Buy | 245p | $280.00 | -12.50% | 12 | May 21, 2026 | |
| LON: CTEC Convatec Group PLC | Reiterated: Buy | 315p | $220.20 | +43.05% | 10 | Mar 11, 2026 | |
| PLLWF Polarean Imaging plc | Maintained: Buy | $0.11 → $0.05 | $0.0066 | +711.55% | 9 | Sep 25, 2025 | |
| AIM: DXRX Diaceutics PLC | Maintained: Buy | 225p | $146.50 | +53.58% | 10 | Sep 23, 2025 | |
| AIM: EKF EKF Diagnostics Holdings plc | Maintained: Buy | 29p → 35p | $26.30 | +33.08% | 5 | Sep 16, 2025 | |
| LON: GNS Genus plc | Maintained: Hold | 1,850p → 2,300p | $2,248.00 | +2.31% | 7 | Sep 9, 2025 | |
| LON: HIK Hikma Pharmaceuticals PLC | Reiterated: Buy | 2,650p | $1,544.00 | n/a | 8 | Apr 24, 2025 | |
| INDV Indivior Pharmaceuticals | Maintained: Buy | $15 | $39.99 | n/a | 4 | Apr 24, 2025 | |
| AIM: UPR Uniphar plc | Reiterated: Buy | 393p → 406p | $398.00 | n/a | 5 | Mar 21, 2025 | |
| FRA: 4YL Nanoform Finland Oyj | Reiterated: Buy | €4.00 | $0.75 | n/a | 3 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.23 | n/a | 4 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 105p | $73.00 | n/a | 3 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €109.00 | $81.95 | n/a | 1 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €229.84 → €248.19 | $26.40 | n/a | 9 | Nov 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 4,481p → 4,107p | $6.82 | n/a | 3 | Jul 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 7,095p → 5,601p | $51.50 | n/a | 2 | May 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 15,533p → 14,040p | $65.00 | n/a | 4 | Jun 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 13,069p | $0.11 | n/a | 3 | May 18, 2017 |
Advanced Medical Solutions Group plc
May 21, 2026
Maintained: Buy
Price Target: 245p
Current: $280.00
Upside: -12.50%
Convatec Group PLC
Mar 11, 2026
Reiterated: Buy
Price Target: 315p
Current: $220.20
Upside: +43.05%
Polarean Imaging plc
Sep 25, 2025
Maintained: Buy
Price Target: $0.11 → $0.05
Current: $0.0066
Upside: +711.55%
Diaceutics PLC
Sep 23, 2025
Maintained: Buy
Price Target: 225p
Current: $146.50
Upside: +53.58%
EKF Diagnostics Holdings plc
Sep 16, 2025
Maintained: Buy
Price Target: 29p → 35p
Current: $26.30
Upside: +33.08%
Genus plc
Sep 9, 2025
Maintained: Hold
Price Target: 1,850p → 2,300p
Current: $2,248.00
Upside: +2.31%
Hikma Pharmaceuticals PLC
Apr 24, 2025
Reiterated: Buy
Price Target: 2,650p
Current: $1,544.00
Upside: n/a
Indivior Pharmaceuticals
Apr 24, 2025
Maintained: Buy
Price Target: $15
Current: $39.99
Upside: n/a
Uniphar plc
Mar 21, 2025
Reiterated: Buy
Price Target: 393p → 406p
Current: $398.00
Upside: n/a
Nanoform Finland Oyj
Nov 19, 2024
Reiterated: Buy
Price Target: €4.00
Current: $0.75
Upside: n/a
Jun 4, 2024
Reiterated: Buy
Price Target: n/a
Current: $1.23
Upside: n/a
May 23, 2024
Maintained: Buy
Price Target: 105p
Current: $73.00
Upside: n/a
Nov 11, 2020
Downgraded: Hold
Price Target: €109.00
Current: $81.95
Upside: n/a
Nov 12, 2018
Reiterated: Buy
Price Target: €229.84 → €248.19
Current: $26.40
Upside: n/a
Jul 25, 2018
Reiterated: Buy
Price Target: 4,481p → 4,107p
Current: $6.82
Upside: n/a
May 24, 2018
Maintained: Buy
Price Target: 7,095p → 5,601p
Current: $51.50
Upside: n/a
Jun 8, 2017
Reiterated: Buy
Price Target: 15,533p → 14,040p
Current: $65.00
Upside: n/a
May 18, 2017
Reiterated: Buy
Price Target: 13,069p
Current: $0.11
Upside: n/a